EveryBaby: AI-enabled handheld device for preterm birth prediction, raising Seed to accelerate Asia clinical rollout

Preterm birth: leading cause of neonatal death, ~15M births/year globally (WHO). EveryBaby's handheld device measures cervical electrical impedance at the point of care and returns a risk score in seconds. No lab required. Status \- UAE: Conditional Approval (DoH Abu Dhabi). PIVOTAL study Q1 2027. \- IP Protected \- Manufacturing: Tier 1 assembly partner secured. Seeking: Seed investors, hospital networks, and distributors across GCC, ASEAN, and Greater China.